As of 2026-06-05, Eli Lilly (LLY) has an overall Buy technical signal, while Novo Nordisk (NVO) reads Sell. Over the last six months LLY returned +12.3% versus NVO at -7.1% (so LLY has outperformed on price). These are automated technical readings for education, not financial advice.
| Metric | LLY | NVO |
|---|---|---|
| Price | $1,135.44 | $43.01 |
| Daily change | +0.90% | -1.68% |
| Overall signal | Buy | Sell |
| Confidence | 75% | 43% |
| 6-month return | +12.3% | -7.1% |
| RSI (14) | 69 | 47 |
| MACD | Buy | Sell |
| Trend | Uptrend | Downtrend |
Eli Lilly full analysis · Novo Nordisk full analysis · Interactive chart →
⚠️ Not financial advice. Automated technical information for education only; indicators are not proven to beat buy-and-hold. © 2026 DailyTechnicals.